Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth E Powell

Showing results (51-60 of 113) with videos related to

Pageof 12
Sort By:
Endocrinology|November 19, 2010
GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolismJohanna L Barclay, Caroline N Nelson, Mayumi Ishikawa, et al.
Australian Health Review : a Publication of the Australian Hospital Association|August 11, 2016
Identifying areas of need relative to liver disease: geographic clustering within a health service districtNathan El-Atem, Katharine M Irvine, Patricia C Valery, et al.
Internal Medicine Journal|June 19, 2022
Differences in the pattern and cost of hospital care between Indigenous and non-Indigenous Australians with cirrhosis: an exploratory studySamath Amarasena, Paul J Clark, Louisa G Gordon, et al.
BMC Health Services Research|April 23, 2020
Protocol for a randomised trial testing a community fibrosis assessment service for patients with suspected non-alcoholic fatty liver disease: LOCal assessment and triage evaluation of non-alcoholic fatty liver disease (LOCATE-NAFLD)David Brain, James O'Beirne, Ingrid J Hickman, et al.
BMC Health Services Research|September 5, 2023
A discrete choice experiment to elicit preferences for a liver screening programme in Queensland, Australia: a mixed methods study to select attributes and levelsMichelle J Allen, Rachael Doran, David Brain, et al.
BMC Health Services Research|April 13, 2022
Implementing the right care in the right place at the right time for non-alcoholic fatty liver disease (NAFLD-RRR study): a study protocol for a community care pathway for people with type 2 diabetesLucy Gracen, Kelly L Hayward, Melanie Aikebuse, et al.
Internal Medicine Journal|February 26, 2020
Changing prevalence of aetiological factors and comorbidities among Australians hospitalised for cirrhosisPatricia C Valery, Steven McPhail, Katherine A Stuart, et al.
Patient Preference and Adherence|September 16, 2024
An Australian Community-Based Metabolic Dysfunction-Associated Steatotic Liver Disease Care Pathway for People with Type 2 Diabetes: Barriers and ConsiderationsLucy Gracen, Melanie Aikebuse, Babak Sarraf, et al.
Gastroenterology|December 14, 2005
Steatosis is a cofactor in liver injury in hemochromatosisElizabeth E Powell, Azmat Ali, Andrew D Clouston, et al.
Hepatology Communications|April 8, 2020
Nonalcoholic Fatty Liver Disease: Interface Between Primary Care and Hepatology ClinicsHarendran Elangovan, Sashen Rajagopaul, Suzanne M Williams, et al.
Pageof 12

Showing results (51-60 of 113) with videos related to

Sort By:
Pageof 12
Endocrinology|November 19, 2010
GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolismJohanna L Barclay, Caroline N Nelson, Mayumi Ishikawa, et al.
Australian Health Review : a Publication of the Australian Hospital Association|August 11, 2016
Identifying areas of need relative to liver disease: geographic clustering within a health service districtNathan El-Atem, Katharine M Irvine, Patricia C Valery, et al.
Internal Medicine Journal|June 19, 2022
Differences in the pattern and cost of hospital care between Indigenous and non-Indigenous Australians with cirrhosis: an exploratory studySamath Amarasena, Paul J Clark, Louisa G Gordon, et al.
BMC Health Services Research|April 23, 2020
Protocol for a randomised trial testing a community fibrosis assessment service for patients with suspected non-alcoholic fatty liver disease: LOCal assessment and triage evaluation of non-alcoholic fatty liver disease (LOCATE-NAFLD)David Brain, James O'Beirne, Ingrid J Hickman, et al.
BMC Health Services Research|September 5, 2023
A discrete choice experiment to elicit preferences for a liver screening programme in Queensland, Australia: a mixed methods study to select attributes and levelsMichelle J Allen, Rachael Doran, David Brain, et al.
BMC Health Services Research|April 13, 2022
Implementing the right care in the right place at the right time for non-alcoholic fatty liver disease (NAFLD-RRR study): a study protocol for a community care pathway for people with type 2 diabetesLucy Gracen, Kelly L Hayward, Melanie Aikebuse, et al.
Internal Medicine Journal|February 26, 2020
Changing prevalence of aetiological factors and comorbidities among Australians hospitalised for cirrhosisPatricia C Valery, Steven McPhail, Katherine A Stuart, et al.
Patient Preference and Adherence|September 16, 2024
An Australian Community-Based Metabolic Dysfunction-Associated Steatotic Liver Disease Care Pathway for People with Type 2 Diabetes: Barriers and ConsiderationsLucy Gracen, Melanie Aikebuse, Babak Sarraf, et al.
Gastroenterology|December 14, 2005
Steatosis is a cofactor in liver injury in hemochromatosisElizabeth E Powell, Azmat Ali, Andrew D Clouston, et al.
Hepatology Communications|April 8, 2020
Nonalcoholic Fatty Liver Disease: Interface Between Primary Care and Hepatology ClinicsHarendran Elangovan, Sashen Rajagopaul, Suzanne M Williams, et al.
Pageof 12